Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Zhejiang Taimei Medical Technology Co Ltd Class H ( (HK:2576) ).
Zhejiang Taimei Medical Technology Co., Ltd. has called a second extraordinary general meeting to be held in Shanghai on June 8, 2026, where shareholders will vote on adopting a new Share Award Scheme. The meeting will also seek approval to authorize the board and its representatives to handle all matters related to implementing and managing this incentive plan, with detailed arrangements outlined in a previously issued circular.
The company has set a closure period for the register of H shares from June 3 to June 8, 2026, to determine eligibility for attending and voting at the meeting. Shareholders are allowed to appoint proxies and must complete specified registration and documentation procedures, underscoring the company’s adherence to corporate governance norms as it introduces the new equity-based incentive scheme.
More about Zhejiang Taimei Medical Technology Co Ltd Class H
Zhejiang Taimei Medical Technology Co., Ltd. is a China-based medical technology company listed in Hong Kong under stock code 2576. The company operates in the healthcare and life sciences technology sector, offering digital and technology-driven solutions to support medical research, clinical development, and related services across mainland China and international markets.
Average Trading Volume: 194,708
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.71B
Find detailed analytics on 2576 stock on TipRanks’ Stock Analysis page.